The historical role of post market surveillance pms of medical devices has been reactive.
Medical device post marketing surveillance.
And post market phases.
Post market surveillance pms is an important part of the regulatory framework for medical devices in europe.
Effective post market surveillance for medical devices post market surveillance pms is defined as a systematic process to derive necessary corrective and preventive actions capa from information on medical devices that are already placed on the market.
Post marketing surveillance guidelines is a collection of processes activities used to monitor the safety effectiveness of medical devices.
Postmarketing surveillance pms also post market surveillance is the practice of monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of pharmacovigilance.
Postmarket requirements also include postmarket surveillance studies required under section 522 of the act as well as post approval studies required at the time of approval of a premarket approval.
Eu postmarket surveillance plans for medical devices pdf.
The medical device regulation mdr lays special emphasis on gathering clinical and safety related data after the approval ce certification process and market access.
It has focused on collating and reporting adverse events such as device malfunctions or patient injuries in order to trigger product returns modifications exchanges and recalls as necessary.
Figure 3 risk managements documents required for the market placement of a medical device compared with a.
The fda adverse event reporting system faers is a computerized information database designed to support the fda s post marketing safety surveillance program for all approved drug and therapeutic.